Awake thoracic surgery for lung cancer treatment: where we are and future perspectives-our experience and review of literature
- PMID: 39806444
- PMCID: PMC11726905
- DOI: 10.1186/s13019-024-03313-6
Awake thoracic surgery for lung cancer treatment: where we are and future perspectives-our experience and review of literature
Abstract
Background: Lung cancer is the first cause of cancer-related death. Awake lung resection is a new frontier of the concept of minimally invasive surgery. Our purpose is to demonstrate the feasibility of this technique for lobar and sublobar lung resection in NSCLC patients.
Methods: We retrospective reviewed all the medical charts of patients who underwent awake lung resection in our center between March 2018 and March 2024, focusing on patients with NSCLC, and we compared our results with the ones found in literature.
Results: Among 45 patients treated with awake lung resections, we selected 15 patients with NSCLC and finally analyzed the results of 12 patients who underwent VATS awake lung resection, 3 lobectomies and 9 wedge resections. The median Charlson comorbidity index (CCI) was 3 and we had 5 patients (41.67%) with a CCI ≥ 4 and a median FEV1 of 56%. We report only 2 conversions to general anesthesia (16.67%) and no conversion to open thoracotomy. We used a nebulizator for the atomization of lidocaine on the lung surface to reduce the cough reflex. Our post-operative results are in line with literature, with a low complication rate (2 patients, 16.67%) and a median length of stay of 5 days. We safely performed a proper lymph node dissection in all 3 lobectomies. Median Overall Survival and Disease-Free Survival were 11 months.
Conclusions: Awake lung resections are a feasible way to perform a minimally invasive surgical procedure in NSCLC patients, with low risk of conversion to open surgery.
Keywords: Awake lung resections; Minimally invasive lung surgery; NSCLC surgery, uniportal VATS surgery; Spontaneous breathing patients; VATS lung resections.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board. Ethical review and approval were waived for this study due to the retrospective nature of the article. Informed consent was obtained from each patient. Consent for publication: The retrospective analysis of the data did not require a specific protocol. Our Institutional Review Board granted approval and waived the requirement for specific informed consent for this retrospective analysis. Surgical informed consent was obtained from all subjects involved in the study. Competing interests: The authors declare no competing interests.
Figures
References
-
- GLOBOCAN. Available Online: https://gco.iarc.who.int/today/en/dataviz/bars?mode=cancer&key=total&gro.... Accessed 21 Jun 2024
-
- Lim E, Batchelor TJP, Dunning J, Shackcloth M, Anikin V, Naidu B, Belcher E, Loubani M, Zamvar V, Harris RA, Dabner L, McKeon HE, Paramasivan S, Realpe A, Elliott D, De Sousa P, Stokes EA, Wordsworth S, Blazeby JM, Rogers CA. Video-assisted thoracoscopic or open lobectomy in early-stage lung cancer. NEJM Evid. 2022;1(3):EVIDoa2100016. 10.1056/EVIDoa2100016. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
